Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

InspireMD, Inc. Capital/Financing Update 2016

Jun 29, 2016

34187_rns_2016-06-29_eb84533e-6250-45c5-90cd-3554b0462982.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm

June 29, 2016

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: InspireMD, Inc.

Registration Statement on Form S-1

File No. 333-210760

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins the request of InspireMD, Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared effective at 4:30 p.m. (Washington, D.C. time) on Thursday, June 30, 2016, or as soon as practicable thereafter.

In connection with the proposed offering of the Company’s securities, copies of the preliminary prospectuses dated June 29, 2016 were distributed to the following persons in the following approximate amounts:

To Whom Distributed Number of Copies
Institutions 22
Syndicate 44
Individuals 669
Total 735

We have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Sincerely,
Dawson James Securities, Inc.
By: /s/ Robert D. Keyser, Jr.
Name: Robert D. Keyser, Jr.
Title: Chief Executive Officer

Field: Page; Sequence: 2; Options: Last

Field: /Page